Media headlines about Fresenius Medical Care Corporation (NYSE:FMS) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Fresenius Medical Care Corporation earned a news impact score of 0.20 on Accern’s scale. Accern also gave press coverage about the company an impact score of 46.0712936881265 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:
A number of analysts have commented on FMS shares. UBS AG reiterated a “sell” rating on shares of Fresenius Medical Care Corporation in a report on Tuesday, July 4th. Royal Bank Of Canada reiterated a “hold” rating and issued a $44.00 price objective on shares of Fresenius Medical Care Corporation in a report on Wednesday, July 5th. Zacks Investment Research upgraded shares of Fresenius Medical Care Corporation from a “hold” rating to a “buy” rating and set a $54.00 price objective for the company in a report on Tuesday, July 11th. BidaskClub downgraded shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Finally, DZ Bank AG restated a “buy” rating on shares of Fresenius Medical Care Corporation in a report on Monday, August 7th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $48.50.
Shares of Fresenius Medical Care Corporation (NYSE FMS) opened at 48.42 on Friday. The stock’s 50 day moving average is $48.56 and its 200-day moving average is $47.22. The firm has a market cap of $29.72 billion, a P/E ratio of 20.78 and a beta of 0.48. Fresenius Medical Care Corporation has a one year low of $38.05 and a one year high of $50.22.
Fresenius Medical Care Corporation (NYSE:FMS) last issued its quarterly earnings results on Tuesday, August 1st. The company reported $0.48 EPS for the quarter, missing the consensus estimate of $0.53 by ($0.05). Fresenius Medical Care Corporation had a return on equity of 11.57% and a net margin of 7.06%. The company had revenue of $4.47 billion for the quarter, compared to analyst estimates of $5.20 billion. During the same period last year, the company posted $0.96 EPS. The business’s revenue for the quarter was up 11.1% on a year-over-year basis. Analysts anticipate that Fresenius Medical Care Corporation will post $2.32 EPS for the current fiscal year.
COPYRIGHT VIOLATION WARNING: “Fresenius Medical Care Corporation (NYSE:FMS) Receiving Somewhat Favorable News Coverage, Report Shows” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.dispatchtribunal.com/2017/10/28/somewhat-positive-media-coverage-somewhat-unlikely-to-affect-fresenius-medical-care-corporation-fms-share-price.html.
About Fresenius Medical Care Corporation
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.